AIG
TEVA icon

American International Group’s Teva Pharmaceuticals TEVA Stock Holding History

American International Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-176,416
Closed -$2.49M – 2445
2024
Q1 		$2.49M Sell
176,416
-11,372
-6% -$143K 0.01% 944
2023
Q4 		$1.96M Sell
187,788
-6,425
-3% -$60K 0.01% 1000
2023
Q3 		$1.98M Buy
194,213
+1,989
+1% +$18.5K 0.01% 958
2023
Q2 		$1.45M Buy
192,224
+488
+0.3% +$3.96K 0.01% 1070
2023
Q1 		$1.7M Buy
191,736
+11,918
+7% +$118K 0.01% 998
2022
Q4 		$1.64M Buy
179,818
+8,088
+5% +$70.6K 0.01% 1005
2022
Q3 		$1.39M Buy
171,730
+8,823
+5% +$78K 0.01% 1052
2022
Q2 		$1.23M Buy
162,907
+479
+0.3% +$4.17K 0.01% 1119
2022
Q1 		$1.52M Buy
162,428
+6,606
+4% +$55.1K 0.01% 1117
2021
Q4 		$1.25M Sell
155,822
-400
-0.3% -$3.61K 0.01% 1290
2021
Q3 		$1.52M Buy
156,222
+6,889
+5% +$64.5K 0.01% 1184
2021
Q2 		$1.48K Buy
149,333
+500
+0.3% +$5.29K 0.01% 1293
2021
Q1 		$1.72K Sell
148,833
-820
-0.5% -$9.4K 0.01% 1186
2020
Q4 		$1.44K Sell
149,653
-100
-0.1% -$958 0.01% 1220
2020
Q3 		$1.35M Buy
149,753
+41
+0% +$434 0.01% 1110
2020
Q2 		$1.85M Buy
149,712
+27,599
+23% +$312K 0.01% 992
2020
Q1 		$1.1M Sell
122,113
-185
-0.2% -$1.9K 0.01% 1075
2019
Q4 		$1.2M Buy
122,298
+4,475
+4% +$40K ﹤0.01% 1246
2019
Q3 		$811K Hold
117,823
– – ﹤0.01% 1404
2019
Q2 		$1.09M Buy
117,823
+10,702
+10% +$129K ﹤0.01% 1270
2019
Q1 		$1.68M Buy
107,121
+1,203
+1% +$21.2K 0.01% 1072
2018
Q4 		$1.63M Sell
105,918
-12,991
-11% -$266K 0.01% 1038
2018
Q3 		$2.56M Sell
118,909
-7,499
-6% -$174K 0.01% 956
2018
Q2 		$3.07M Buy
126,408
+6,487
+5% +$132K 0.01% 888
2018
Q1 		$2.05M Buy
119,921
+7,431
+7% +$145K 0.01% 981
2017
Q4 		$2.13M Buy
112,490
+9,601
+9% +$144K 0.01% 994
2017
Q3 		$1.81M Buy
102,889
+6,289
+7% +$142K 0.01% 1031
2017
Q2 		$3.21M Buy
96,600
+80,300
+493% +$2.49M 0.01% 857
2017
Q1 		$523K Buy
+16,300
New +$556K ﹤0.01% 1568
2016
Q2 		– Sell
-7,848
Closed -$420K – 4322
2016
Q1 		$420K Sell
7,848
-7,351
-48% -$431K ﹤0.01% 2132
2015
Q4 		$997K Buy
15,199
+3,591
+31% +$222K ﹤0.01% 1516
2015
Q3 		$654K Sell
11,608
-86
-0.7% -$5.58K ﹤0.01% 1782
2015
Q2 		$691K Buy
11,694
+602
+5% +$37.1K ﹤0.01% 1891
2015
Q1 		$691K Buy
11,092
+1,436
+15% +$83.5K ﹤0.01% 1906
2014
Q4 		$555K Sell
9,656
-5,359
-36% -$299K ﹤0.01% 2044
2014
Q3 		$807K Buy
15,015
+130
+0.9% +$6.89K ﹤0.01% 1730
2014
Q2 		$780K Sell
14,885
-2,076
-12% -$106K ﹤0.01% 1783
2014
Q1 		$896K Sell
16,961
-3,615
-18% -$167K ﹤0.01% 1615
2013
Q4 		$825K Sell
20,576
-3,025
-13% -$119K ﹤0.01% 1613
2013
Q3 		$892K Sell
23,601
-5,217
-18% -$204K ﹤0.01% 1507
2013
Q2 		$1.13M Buy
+28,818
New +$1.12M 0.01% 1306

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's TEVA Position: Q2 2024 in Review

American International Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 176,416 shares — an estimated $2.49M sold.

American International Group first reported a position in TEVA in Q2 2013 and held it in 41 quarters. The position peaked at $3.21M in Q2 2017. 533 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • American International Group reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 176,416 Teva Pharmaceuticals shares in Q2 2024, an estimated $2.49M.
  • American International Group first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 41 quarters.
  • American International Group's Teva Pharmaceuticals position peaked at $3.21M in Q2 2017.
  • 533 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.